Berman Howard bought AVIR
June 20, 2025 · Form 4 insider transaction
Berman Howard bought 164,800 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
164,800
Price
$0.00
Total value
N/A
InsiderBerman Howard
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 20, 2025
Filing dateJune 24, 2025
Shares owned after164,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable in thirty-six (36) equal monthly installments following June 20, 2025 such that the option is fully vested on June 20, 2028.